Log In
Print
BCIQ
Print
Print this Print this
 

HuMax-TF-ADC

  Manage Alerts
Collapse Summary General Information
Company Genmab A/S
DescriptionAntibody-drug conjugate (ADC) against tissue factor
Molecular Target Tissue factor
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today